FGF19 Gene Amplification
1 clinical trials · Condition
◉ Watch FGF19 Gene Amplification
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations (NCT06915753) | Tyra Biosciences, Inc | 2025-04-24 |
Track FGF19 Gene Amplification automatically
Every clearance here is in the API, with alerts when new ones post.